Cargando…
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples
Cenobamate (CNB) is the newest antiseizure medication (ASM) approved by the FDA in 2019 to reduce uncontrolled partial-onset seizures in adult patients. Marketed as Xcopri in the USA or Ontozry in the EU (tablets), its mechanism of action has not been fully understood yet; however, it is known that...
Autores principales: | Charlier, Bruno, Coglianese, Albino, Operto, Francesca Felicia, Coppola, Giangennaro, de Grazia, Ugo, Menna, Pierantonio, Filippelli, Amelia, Dal Piaz, Fabrizio, Izzo, Viviana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656984/ https://www.ncbi.nlm.nih.gov/pubmed/36364153 http://dx.doi.org/10.3390/molecules27217325 |
Ejemplares similares
-
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications
por: Charlier, Bruno, et al.
Publicado: (2021) -
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents
por: Charlier, Bruno, et al.
Publicado: (2023) -
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples
por: Molteni, Linda, et al.
Publicado: (2023) -
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain
por: De Rosa, Federica, et al.
Publicado: (2023) -
A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature
por: Conti, Valeria, et al.
Publicado: (2020)